Dr Khatun E Zannat, Assistant Professor, Department of Pharmacology, Diabetic Association Medical College, Faridpur, Bangladesh; E-mail:
Mymensingh Med J. 2023 Jul;32(3):620-626.
Evaluation of the in vitro antibacterial activity of Chloroform extracts isolated from Henna (Lawsonia inermis) leaf against two nosocomial infection causing pathogens, gram-positive Staphylococcus aureus and gram-negative Klebsiella pneumoniae. This interventional study was carried out for the period of January 2021 to December 2021 in the Department of Pharmacology and Therapeutics in collaboration with the Department of Microbiology, Mymensingh Medical College, Bangladesh. The antibacterial activity was tested at different concentrations of Chloroform Henna leaf extracts by using disc diffusion and broth dilution method. The extract was prepared by using solvents chloroform and 0.1% Dimethyl sulfoxide (DMSO). The test microorganisms were also tested for their activity against a standard antibiotic Ciprofloxacin by broth dilution method and the result was compared with that of Chloroform extracts. Chloroform Henna Extracts (CHE) were used initially in nine different concentrations (2.5, 5, 10, 20, 50, 100, 200, 500 and 1000 mg/ml). Among different concentrations of the CHE, 100mg/ml and above concentrations showed inhibitory effect against Staphylococcus aureus and Klebsiella pneumoniae. The MIC for Staphylococcus aureus and Klebsiella pneumoniae were 100 and 200mg/ml in CHE respectively. The MIC of Ciprofloxacin was 1μg/ml against Staphylococcus aureus and 1.5μg/ml against Klebsiella pneumoniae. The MIC of Ciprofloxacin was the lowest in comparison to MICs of CHE for the test organisms. This study showed that Chloroform Henna extracts demonstrated antibacterial effects against food borne pathogens. It is clearly observed that there is definite antibacterial effect of the Chloroform extract of Henna leaves (Lawsonia inermis) against Staphylococcus aureus and Klebsiella pneumoniae.
评估氯仿提取物对两种医院感染病原体的体外抗菌活性,革兰氏阳性金黄色葡萄球菌和革兰氏阴性肺炎克雷伯菌。这项干预性研究于 2021 年 1 月至 2021 年 12 月在孟加拉国 Mymensingh 医学院药理学和治疗学系与微生物学系合作进行。采用纸片扩散法和肉汤稀释法检测不同浓度氯仿凤仙花叶提取物的抗菌活性。提取物采用氯仿和 0.1%二甲基亚砜(DMSO)溶剂制备。采用肉汤稀释法检测试验微生物对标准抗生素环丙沙星的活性,并与氯仿提取物的结果进行比较。氯仿凤仙花提取物(CHE)最初用于 9 种不同浓度(2.5、5、10、20、50、100、200、500 和 1000mg/ml)。在不同浓度的 CHE 中,100mg/ml 及以上浓度对金黄色葡萄球菌和肺炎克雷伯菌有抑制作用。金黄色葡萄球菌和肺炎克雷伯菌的 CHE 的 MIC 分别为 100 和 200mg/ml。环丙沙星对金黄色葡萄球菌的 MIC 为 1μg/ml,对肺炎克雷伯菌的 MIC 为 1.5μg/ml。与 CHE 的 MIC 相比,环丙沙星的 MIC 最低。本研究表明,氯仿凤仙花提取物对食源性病原体具有抗菌作用。显然,氯仿凤仙花叶提取物对金黄色葡萄球菌和肺炎克雷伯菌有明确的抗菌作用。